-
1Academic Journal
Συγγραφείς: A. V. Bairashevskaya, O. V. Kytko, А. В. Байрашевская, О. В. Кытько
Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 66, № 2 (2021); 21-28 ; Российский вестник перинатологии и педиатрии; Том 66, № 2 (2021); 21-28 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2021-66-2
Θεματικοί όροι: тромбэктомия, newborns, neonatal thrombosis, hemostasis, heparin, dabigatran, thrombectomy, новорожденные, неонатальные тромбозы, гемостаз, гепарин, дабигатран
Περιγραφή αρχείου: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/1369/1068; Shaik M., Patel D., Mihir B., Chan A.K.C., Paes B. Epidemiology, Diagnosis and Management of Neonatal Thrombosis. Blood 2019; 134: 3656. DOI:10.1182/blood-2019-129914; Szpecht D., Szymankiewicz M., Nowak I., Gadzinowski J Intraventricular hemorrhage in neonates born before 32 weeks of gestation-retrospective analysis of risk factors. Childs Nerv Syst 2016; 32: 1399–1404. DOI:10.1007/s00381-016-3127-x; Bikdeli B., Jiménez D., Hawkins M., Ortíz S., Prandoni P., Brenner B. et al. Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE). Thromb Haemost 2018; 118(1): 214–224. DOI:10.1160/TH17-07-0511; Sirachainan N., Limrungsikul A., Chuansumrit A., Nuntnarumit P., Thampratankul L., Wangruangsathit S. et al. Incidences, risk factors and outcomes of neonatal thromboembolism, J Matern Fetal Neonatal Med 2018; 31:347–351. DOI:10.1080/14767058.2017.1285892; Haley K.M. Neonatal Venous Thromboembolism. Front Pediatr 2017; 5: 136–142. DOI:10.3389/fped.2017.00136; Sewell E.K., Forman K.R., Wong E.C.C., Gallagher M., Luban N.L.C., Massaro A.N. Thromboelastography in term neonates: an alternative approach to evaluating coagulopathy. Arch. Dis. Child Fetal Neonatal Ed 2017; 102: F79–F84. DOI:10.1136/archdischild-2016-310545; Roshdy E.A. White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis. Case Med Res 2019 https://clinicaltrials.gov/ct2/show/NCT03880305; Koltsova E.M., Balandina A.N., Grischuk K.I., Shpilyuk M.A., Dashkevich N.M., Poletaev A.V. et al. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery. J Perinat Med 2018; 46:251–260. DOI:10.1515/jpm-2016-0333; Khan A.O., Pike J.A. Super-resolution imaging and quantification of megakaryocytes and platelets. Platelets 2020; 1: 1–11. DOI:10.1080/09537104.2020.1732321; Krapivina E.V., Novikova T.V. Functional features of hemostasis in physically weakened newborn piglets and calves. BIO Web of Conferences 2020; 17: 1-5. DOI:10.1051/bioconf/20201700162; Ngo A.T.P., Sheriff J., Rocheleau A.D., Bucher M., Jones K.R., Sepp A.L.I. et al. Assessment of neonatal, cord, and adult platelet granule trafficking and secretion. Platelets 2020; 31(1): 68–78. DOI:10.1080/09537104.2019.1573314; Cott E.V., Smock K., Lippi G. Innovations in Thrombosis and Hemostasis: A Glimpse Towards the Future of Diagnostic Analyzers. Sem Thromb Hemost 2019; 45(3): 225–227. DOI:10.1055/s-0039-1683844; Ferrer-Marin F., Liu Z.J., Gutti R., Sola-Visner M. Neonatal Thrombocytopenia and Megakaryocytopoiesis. Semin Hematol 2010; 47: 281–8. DOI:10.1053/j.seminhema-tol.2010.04.002; Meyer A.D., Rishmawi A.R., Kamucheka R., Lafleur C., Batchinsky A.I., Mackman N. et al. Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation. J Thromb Haemost 2020; 18(2): 399–410. DOI:10.1111/jth.14661; Urban D., Pluthero F., Christensen H., Baidya Sh., Rand M., Das A. et al. Decreased numbers of dense granules in fetal and neonatal platelets. Haematol 2017; 102:e36–8. DOI:10.3324/haematol.2016.152421; Sitaru A.G., Holzhauer S., Speer C.P., Singer D., Obergfell A., Walter U., Grossmann R. Neonatal platelets from cord blood and peripheral blood. Platelets 2005; 16:203–10. DOI: org/10.1080/09537100400016862; Haley K., Recht M., McCarty O. Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res 2014; 76: 230–237. DOI:10.1038/pr.2014.87; Monagle P. Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation? Thromb Res 2019; 173: 186–190. DOI:10.1016/j.thromres.2018.07.016; Kenet G., Cohen O., Bajorat T., Nowak-Göttl U. Insights into neonatal thrombosis. Thromb Res 2019; 181: S33–S36. DOI:10.1016/s0049-3848(19)30364-0; Federici E., Al-Mondhiry H. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A. Thromb Res 2019; 182:75–78. DOI:10.1016/j.thromres.2019.07.030; Черкасова С.В. Гемостаз новорожденных. Практика педиатра 2020; 1:49–52. [Cherkasova S.V. Hemostasis of the newborn. Praktika pediatra 2020; 1:49–52. (in Russ.)]; Heavey E. Screening newborns for critical congenital heart defects. Nursing 2019; 49(1):17–18. DOI:10.1097/01.nurse.0000549738.60681.f8; Koltsova E.M., Balashova E.N., Ignatova A.A., Poletaev A.V., Polokhov D.M., Kuprash A.D. et al. Impaired platelet activity and hypercoagulation in healthy term and moderately preterm newborns during the early neonatal period. Pediatr Res 2019; 85:63–71. DOI:10.1038/s41390-018-0184-8; Yurdakök K., Oran O., Tekinalp G., Dündar S., Yurdakök M. Plasma Protein C and Antithrombin III Levels in Polycythemic Newborns. J Pediatr Hematol Oncol 1989; 6(1):59–61. DOI:10.3109/08880018909014583; Marco A., Marco P. Cerebral Venous Thrombosis in a Pediatric Patient with Antithrombin Deficiency. J Clinical Case Rep Case Stud 2019; 2(1):16–20. DOI:10.29199/2637-9309/cccs.201020; Koltsova E.M., Balandina A.N., Grischuk K.I., Shpilyuk M.A., Seregina E.A., Dashkevich N.M. et al. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery. J Perinat Med 2017; 46(3):251–260. DOI:10.1515/jpm-2016-0333; Nowak-Göttl U., Limperger V., Kenet G., Degenhardt F., Arlt R., Domschikowski J. et al. Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2–13. DOI:10.1016/j.bcmd.2016.11.012; Lokeshwar M.R., Sachdeva A. Fetal & Neonatal Hematology, Oncology and Immunology. London, Jaypee Brothers Medical Publishers; first edition. 2017; 135–137; Lee J.W., Her S.M., Kim J.H., Lee K.H., Eisenhut M., Park S.J., Shin J.I. D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection. Pediatr Nephrol 2018; 33(4):631–637. DOI:10.1007/s00467-017-3843-9; Asakura H., Takahashi H., Uchiyama T., Eguchi Y., Okamoto K., Kawasugi K. et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thrombosis J 2016; 14(1): 42. DOI:10.1186/s12959-016-0117-x; Sharma A. Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-Center Experience. Iran J Pathol 2018; 13(2):272–275. DOI:10.30699/ijp.13.2.272; Stefanov G., Puppala B.L., Pais G., Gulati A. Endothelin-1 levels, and renal function in newborns of various gestational ages. J Neonatal Perinatal Med 2016; 9:145–152. DOI:10.3233/NPM-16915078; El Shemi M.S., Tawfik S., Khafagy S.M., Hamza M.T., Youssef A.M.A. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome. J Neonatal Perinatal Med 2017; 10:79–83. DOI:10.3233/NPM-1653; Sewell E.K., Forman K.R., Wong E.C.C., Gallagher M., Luban N.L.C., Massaro A.N. Thromboelastography in term neonates: an alternative approach to evaluating coagulopathy. Arch Dis Child Fetal Neonatal Ed 2017; 102: F79–84. DOI:10.1136/archdischild-2016-310545; Gracheva M.A., Urnova E.S., Sinauridze E.I., Tarandovskiy I.D., Orel E.B., Poletaev A.V. et al. Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma 2015; 56: 3418–3425. DOI:10.3109/10428194.2015.1041385; Koltsova E.M., Balashova E.N., Panteleev M.A., Balandina A.N. Laboratory aspects of hemostasis in neonates. Pediatr Hematol Oncol Immunopathol 2018; 17(4): 100–113. DOI:10.24287/1726-1708-2018-17-4-100-113; Strauss T., Elisha N., Ravid B., Rosenberg N., Lubetsky A., Levy-Mendelovich S. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full-term neonates, Blood Cell Mol Dis 2017; 67: 14–17. DOI:10.1016/j.bcmd.2016.12.013; Mutch N.J., Koikkalainen J.S., Fraser S.R., Duthie K.M., Griffin M., Mitchell J. et al. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost 2010; 8(9): 2017–24. DOI:10.1111/j.1538-7836.2010.03963.x; Bhat R., Monagle P. Anticoagulation in preterm and term neonates: Why are they special? Thromb Res 2020; 187: 113– 121. DOI:10.1016/j.thromres.2019.12.019; Baker-Groberg S.M., Lattimore S., Recht M., McCarty O.J.T., Haley K.M. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost 2016; 14: 815–827. DOI:10.1111/jth.13270; Кольцова Е.М., Балашова Е.Н., Пантелеев М.А., Баландина А.Н. Лабораторные аспекты гемостаза новорожденных. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2018; 17(4): 100–113. [Kol’cova E.M., Balashova E.N., Panteleev M.A., Balandina A.N. Laboratory aspects of hemostasis in newborns. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2018; 17(4): 100–113. (in Russ.)]; Abentaeva B., Charipova B., Aubakirova B. Clinical case neonatal thrombosis of preterm newborn. J Cllin Med Kaz 2017; 3(45):84–88. DOI:10.23950/1812-2892-JCMK-00481; Darwood R., Berridge D.C., Kessel D.O., Robertson I., Forster R. Surgery versus thrombolysis for initialmanagement of acute limb ischaemia. Cochrane Database Syst Rev 2018; 8: CD002784. DOI:10.1002/14651858.CD002784.pub3; Федеральные клинические рекомендации по диагностике, профилактике и лечению тромбозов у детей и подростков. ФГБУ «ФНКЦ ДГОИ имени Дмитрия Рогачева» Минздрава России и Национальное общество детских гематологов, онкологов России 2015 г. [Federal clinical guidelines for the diagnosis, prevention and treatment of thrombosis in children and adolescents. FSBI “FNKTS DPOI named after Dmitry Rogachev” of the Ministry of Health of Russia and the National Society of Pediatric Hematologists, Oncologists of Russia 2015; http://nodgo.org/sites/default/files/34.%20Тромбозы.pdf]; Moustafa F., Pesavento R., Micco P.D., González-Martínez J., Quintavalla R., Peris M.l. et al. Real-life use of anticoagulants in venous thromboembolism, with focus on patients with exclusion criteria for direct oral anticoagulants. Clin. Pharmacol. Ther. 2018; 103: 684–691. DOI:10.1002/cpt.781; Monagle P., Cuello C.A., Augustine C., Bonduel M., Brandão L.R., Capman T. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2: 3292–3316. DOI:10.1182/bloodadvances.2018024786; Iijima S. Seasonal and meteorological associations of vitamin K-dependent coagulation factors in 1-month-old infants. Blood Coagul Fibrinols 2020; 31(3): 233–236. DOI:10.1097/mbc.0000000000000896; Brett O.F., Brett C.N., Chin P.K.L. The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population. Anaesth Intens Care 2019; 47(2): 183–188. DOI:10.1177/0310057x19841009; Dieffenbach B. V., Nath B.D., Tracy E.T., Kim H.B. Management of symptomatic neonatal aortic thrombosis: When is surgery indicated? J Pediatr Surg Case Rep 2019; 47: 1–4. DOI:10.1016/j.epsc.2019.101247; Utne K.K., Dahm A., Wik H.S., Jelsness-Jørgensen L.P., Sandset P.M., Ghanima W. Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Thromb Res 2018; 163: 6–11. DOI:10.1016/j.thromres.2018.01.013; Houghton D.E., Casanegra A., Peterson L.G., Cochuyt J., Hodge D.O., Vlazny D. et al. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Blood 2019; 134(1): 2158. DOI:10.1182/blood-2019-125099; Mantis C., Alexopoulos D. Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner? Thromb Res 2019; 176: 133–139. DOI:10.1016/j.thromres.2019.02.022; Sol J.S., Loo M., Boerma M., Bergman K.A., Donker A.E., van der Hoeven M.A. et al. NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related thrombosis. BMC Pediatr 2018; 18(1): 84. DOI:10.1186/s12887-018-1000-7; Аксенов Д.В., Чусов К.П., Рябкова М.Г., Свирин П.В., Кругляков А.Ю., Дубенок С.Ю. Тромболитическая терапия у новорожденного с массивным артериовенозным тромбозом. Опыт Морозовской детской городской клинической больницы. Неонатология: новости, мнения, обучение 2019; 7(2): 59–67. [Aksenov D.V., Chusov K.P., Ryabkova M.G., Svirin P.V., Kruglyakov A.Yu., Dubenok S.Yu. Thrombolytic therapy in a newborn with massive arteriovenous thrombosis. Experience of the Morozov Children’s City Clinical Hospital. Neonatologiya: novosti, mneniya, obuche- nie 2019; 7(2): 59–67. (in Russ.)]; Puangpunngam N. Endovascular thrombectomy versus open surgical thrombectomy for thrombosed arteriovenous hemodialysis graft. Siriraj Med J 2019; 71(6): 491–498. DOI:10.33192/smj.2019.73; Cournoyer-Rodrigue J., Bui T.B., Gilbert P., Soulez G., Perreault P., Bouchard L. et al. Percutaneous Thrombectomy with the JETi8 Peripheral Thrombectomy System for the Treatment of Deep Vein Thrombosis. J Vascular and Interventional Radiology 2020; 31(3): 444–453. DOI: org/10.1016/j.jvir.2019.10.022; Nurmeev I.N., Kostromin A.A., Okoye B. Treatment of the newborn with a floating thrombus in the right atrium: case report. Russ Open Med J 2019; 8:e0111; Ivlev D.A., Shirinli S.N., Guria K.G., Uzlova S.G., Guria G.T. Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation. PLOS ONE 2019: 1–17. DOI:10.1371/journal.pone.0211646
-
2Academic Journal
Συγγραφείς: M. A. Mingalimov, K. N. Grigorieva, M. V. Tretyakova, I. Elalamy, Kh. G. Sultangadzhieva, V. O. Bitsadze, J. Kh. Khizroeva, A. D. Makatsariya, М. А. Мингалимов, К. Н. Григорьева, М. В. Третьякова, И. Элалами, Х. Г. Султангаджиева, В. О. Бицадзе, Д. Х. Хизроева, А. Д. Макацария
Πηγή: Obstetrics, Gynecology and Reproduction; Vol 14, No 1 (2020); 56-68 ; Акушерство, Гинекология и Репродукция; Vol 14, No 1 (2020); 56-68 ; 2500-3194 ; 2313-7347
Θεματικοί όροι: неонатальные тромбозы, DIC, perinatal medicine, thromboses, hemostatic disorders, anticoagulant therapy, gestation, neonatal thromboses, перинатальная медицина, тромбозы, нарушение гемостаза, антикоагулянтная терапия, гестация
Περιγραφή αρχείου: application/pdf
Relation: https://www.gynecology.su/jour/article/view/625/780; Зыятдинов К.Ш., Белопухов В.М., Якупов И.Ф. и др. Синдром диссеминированного внутрисосудистого свертывания при инфаркте миокарда. Вестник современной клинической медицины. 2014;7(5):34-9.; Макацария А.Д., Панфилова О.Ю. К вопросу о ДВС-синдроме в акушерстве: новое о старом. Практическая медицина. 2010;(4):25-37.; Trousseau A. Phlegmasia alba dolens. Clin Med Hotel Dieu Paris. 1865;3:695.; Ratnoff O.D., Pritchard J.A., Colopy J.E. et al. Hemorrhagic states during pregnancy. N Engl J Med. 1955;253(3):97-102. DOI:10.1056/NEJM195507212530305.; Lasch H.G., Heene D.L., Huth K., Sandritter W. Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy («Verbrauchskoagulopathie»). Am J Cardiol. 1967;20(3):381—91. DOI:10.1016/0002-9149(67)90062-8.; McKay D.G. Disseminated intravascular coagulation: an intermediary mechanism of disease. New York: Hoeber Medical Division of Harper and Row, 1965. 392 p.; Lisman T., Luyendyk J.P. Platelets as modulators of liver disease. Semin Thromb Hemost. 2018;44(2):114-25. DOI:10.1055/s-0037-1604091.; Abbassi-Ghanavati M., Greer L.G., Cunningham F.G. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326-31. DOI:10.1097/A0G.0b013e3181c2bde8.; Levi M., Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341(8):586-92. DOI:10.1056/NEJM199908193410807.; Uszynski M., Zekanowska E., Uszyński W., Kuczyński J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol. 2001;95(2):163-6. DOI:10.1016/s0301-2115(00)00448-6.; Boer K., den Hollander I.A., Meijers J.C., Levi M. Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery. J Thromb Haemost. 2007;5(12):2415—20. DOI:10.1111/j.1538-7836.2007.02767.x.; Williams obstetrics. Eds. F. Cunningham, K.J. Leveno, S.L. Bloom et al. 25th ed. New York (NY): McGraw-Hill, 2018. 1328 p.; Kuczynski J., Uszyński W., Zekanowska E. et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet GynecolReprod Biol. 2002;105(1):15—9. DOI:10.1016/s0301-2115(02)00113-6.; Pritchard J.A., Brekken AL. Clinical and laboratory studies on severe abruptio placentae. Am J Obstet Gynecol. 1967;97(5):681—700. DOI:10.1016/0002-9378(67)90454-1.; Макацария А.Д., Панфилова О.Ю. Эмболия околоплодными водами или анафилактоидный синдром беременности. Практическая медицина. 2010;(43):13-9.; Clark S.L. Amniotic fluid embolism. Obstet Gynecol. 2014;123(2 Pt 1):337—48. DOI:10.1097/A0G.0000000000000107.; Nelson D.B., Yost N.P., Cunningham F.G. Hemostatic dysfunction with acute fatty liver of pregnancy. Obstet Gynecol. 2014;124(1):40—6. DOI:10.1097/AOG.0000000000000296.; Sibai B.M. Imitators of severe preeclampsia. Obstet Gynecol. 2007;109(4):956--66. DOI:10.1097/01.AOG.0000258281.22296.de.; Vigil-de Gracia P., Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med. 2011;24(9):1143—6. DOI:10.3109/14767058.2010.531325.; Russell J.A. Management of sepsis. N Engl J Med. 2006;355(16):1699— 713. DOI:10.1056/NEJMra043632.; Moellering R.C., Abbott G.F., Ferraro M.J. Case records of the Massachussets General Hospital Case 2-2011. A 30-year-old woman with shock after treatment for a furuncle. N Engl J Med. 2011;364(3):266—75. DOI:10.1056/NEJMcpc1003886.; Mabie W.C., Barton J.R., Sibai B. Septic shock in pregnancy. Obstet Gynecol. 1997;90(4 Pt 1):553-61. DOI:10.1016/s0029-7844(97)00352-9.; Barton J.R., Sibai B.M. Severe sepsis and septic shock in pregnancy. Obstet Gynecol. 2012;120(3):689-706. DOI:10.1097/AOG.0b013e318263a52d.; Sheffield J.S., Cunningham F.G. Urinary tract infection in women. Obstet Gynecol. 2005;106(5 Pt 1):1085-92. DOI:10.1097/01.AOG.0000185257.52328.a2.; Wenzel R.P., Edmond M.B. Septic shock-evaluating another failed treatment. N Engl J Med. 2012;366(22):2122-4. DOI:10.1056/NEJMe1203412.; Hypertensive disorders in pregnancy. Ed. L.C. Chesley. New York (NY): Appleton-Century-Crofts, 1978. 628 р.; Pritchard J.A., Cunningham F.G., Mason R.A. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976;124(8):855-64. DOI:10.1016/s0002-9378(16)33390-7.; Jimenez J.M., Pritchard J.A. Pathogenesis and treatment of coagulation defects resulting fetal death. Obstet Gynecol. 1968;32(4):449-59.; Kramer M.S., Berg C., Abenhaim H. et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):449.e1-7. DOI:10.1016/j.ajog.2013.07.007.; Erez O., Novack L., Beer-Weisel R. et al. DIC score in pregnant women - a population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One. 2014;9(4):e93240. DOI:10.1371/journal.pone.0093240.; Roberts I., Murray N.A. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F359-64. DOI:10.1136/fn.88.5.F359.; Levi M., Toh C.H., Thachil J., Watson H.G. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145(1):24-93. DOI:10.1111/j.1365-2141.2009.07600.x.; Levi M., Meijers J.C. DIC: which laboratory tests are most useful. Blood Rev. 2011;25(1):33-7. DOI:10.1016/j.blre.2010.09.002.; Момот А.П., Мамаев А.Н. Современные аспекты патогенеза, диагностики и терапии ДВС-синдрома. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2008;1(1):63-71.; Hunt B.J. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370(9):847-59. DOI:10.1056/NEJMra1208626.; Josic D., Hoffer L., Buchacher A. et al. Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity. Thromb Res. 2000;100(5):433-41. DOI:10.1016/S0049-3848(00)00339-X.; Kreuz W., Meili E., Peter-Salonen K. et al. Efficacy and tolerability of a pasteurized human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci. 2005;32(2):247-53. DOI:10.1016/j.transci.2004.08.003.; Weinkove R., Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med. 2008;18(3):151-7. DOI:10.1111/j.1365-3148.2008.00854.x.; Corrigan J.J., Jordan C.M. Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med. 1970;283(15):778-82. DOI:10.1056/NEJM197010082831502.; Kobayashi T., Teraro T., Ikenoue T. et al. B151017 Study Group. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Semin Thromb Hemost. 2003;29(6):645-52. DOI:10.1055/s-2004-815632.; Bernard G.R., Vincent J.L., Laterre P.F. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699—709. DOI:10.1056/NEJM200103083441001.; Edwards H.M. Aetiology and treatment of severe postpartum haemorrhage. Dan Med J. 2018;65(3). pii: B5444.; https://www.gynecology.su/jour/article/view/625